COMPANY

History

2023
12
Hosted LSK Global PS and Target Health Joint Seminar
03
LSK symposium “Innovative Future in Clinical trials”
01
Acquired Information Security Management Systems ISO 27001:2013 certification
2022
05
Acquired Compliance management systems ISO 37301:2021 certification
04
MOU with CLUPEA for the introduction of CDISC Data Management Platform (MediLake)
03
Established a Training Internship program to educate CRO service specialists
01
Academic Research Service (ARS) division for academic medical science research expertise service
01
MOU with A Leading Yonsei Network for Biopharmaceutical R&D for healthcare Big Data research
2021
11
Clinical trial document management solution ‘Maven Docs’ co-development with JNPMedi
06
Held the 1st Anticancer Drug Phase 1 Statistical Symposium in 2021
03
LSK Global PS obtains ISO 14155 certificate for medical device clinical trial management assurance for medical device global market expansion
01
LSK Global PS and Daewoong Pharmaceutical execute an MOU for co-development of Foistar Tab (Camostat Mesylate) for COVID-19 treatment
01
LSK Global PS and Korea University Medicine execute an MOU for drug and medical device clinical trial cooperation
2020
07
Published “Understanding of clinical trial practice of a leading CRO in Korea” to commemorate the 20th anniversary
03
LSK Global PS, MOU with Gangnam Severance Hospital, YonSei University for mutual cooperation for clinical trials & research outcomes
02
Established a Data Management branch office of LSK Global Pharma Services Co., Ltd. in Taiwan (LSK Taiwan)
2019
12
Acquired the ‘ISO 37001’ certification for Anti-Bribery Management Systems from the International Organization for Standardization (ISO) for the first time as a CRO
06
Accredited as a Certified Clinical Data Manager (CCDM®) Industry Partner by the Society for Clinical Data Management (SCDM) which is a non-profit international organization serving global clinical data management for the first time as a CRO providing a full service for clinical trials in Korea
05
Established the ‘Pharmacovigilance (PV) EU branch office’ in Warsaw, Poland for the first time as a CRO in Korea
02
Established LSK NRDO (No Research Development Only), a subsidiary company dedicated to new drug development
2018
11
Vice president DaeHee Shin of BNS Division received commendation for his contribution to Bioindustry from the Minister of Science and ICT
06
Young-Jack Lee, the CEO of LSK Global PS participated as the first Korean panelist in the discussion session of the DIA 2018 Annual Meeting and shared his view on the ways to improve patient engagement in clinical trials as well as the current state of clinical trials in Korea
03
Surpassed 1,000 contracts for the conduct of clinical trials by LSK Global PS
2017
12
Cerified as the first CRO with family friendly Company by Korea Ministry of Gender Equality and Family
11
LSK Global PS & Chemon, Non-clinical Service CRO, MOU to Maximize Joint Research and Development Competencies of New Drugs
09
LSK Global PS & DKSH Korea, MOU for Strategic Expansion of the Pharmaceutical Market Services
05
CEO, Young-Jack Lee awarded by MOHW, Recognition of contribution for field of clinical trials
03
LSK Global PS, First to Acquire ‘ISO 9001’ Certification for All Areas of Clinical Trial Services in Korean CRO Industry
01
Obtained the IND approval for a phase 3 global clinical trial on apatinib
2016
08
Introduction of ArisGlobal Safety Database
08
LSK Education Center, Designated as an Education Center for Clinical Research by MFDS
08
Started Medidata Intelemage
06
Started Medidata CTMS first among CROs in Korea
04
LSK SMO was established as a separate legal entity
03
Strategic Alliance with LSK BioPharma for global clinical trials for Apatinib
03
MOU with Konyang Univiersity to develop the talents
2015
10
Introduced Oracle Health Sciences InForm
05
Elected first chairperson of the Korean Association of Clinical CROs
04
Signed agreement with Clinical Trial center of Seoul National University Hospital
2013
04
President appointed as 'Korean Society of Health Information and Health Statistics' Advisor
2012
09
President appointed as ‘Emerging Medicine Market Expansion and Export Consultant’ Expert Advisor
05
Office relocated from Seocho-dong, Seoul to Myeong-dong, Seoul
05
Organized seminar on "Outcome Research" [Seoul, Korea]
02
Organized seminar on "Multinational Clinical ResearchTrials & CDM" [Seoul, Korea]
2011
09
Joined Asia CRO Alliance (Korea, Japan, Chaina, Taiwan, India, Malaysia)
09
Signed alliance agreement with MakroCare
06
Signed agreement with Medidata Solutions, Inc
01
Signed agreement with Guro Hospital, Korea University
2010
10
Organized seminar on "Data Management & e*CRF in Korea 2010"
08
Initiated Electronic Data Capture Service with Target e*Studio
07
Received certification from the Korea Industrial Technology Association for CDM Research and Development Office
05
The First CRO in Korea who won a contract for an FIH(First In Human) Oncology study, selected as a joint project CRO from the Eli Lilly, Chorus which is the autonomous R&D unit within Lilly
04
Signed agreement with Clinical Trial Center, Dongguk University
2009
11
Signed agreement with Clinical Trial Center, Dankook University
2007
11
Office relocated from Yeoksam-dong, Seoul to Seocho-dong, Seoul
08
Company name was changed from Lifecord Stat-Korea, Inc to LSK Global Pharma Service Co, Ltd
2006
05
Joined ACTN [Asia Clinical Trials Network]
01
Established partnership with Target Health, Inc. in Clinical Research & Regulatory Consulting
2005
07
Award for Appreciation to LSK CEO by KFDA
01
Initiated CDM System service with DMSys
01
Established partnership with MDS Pharma Services in Canada
2001
12
Lifecord and Westat-Korea merged to form Lifecord Stat-Korea, Inc.
01
Westat-Korea was reestablished
2000
03
Westat Korea was established [Westat, Inc. Korea branch]